tiprankstipranks
Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Holding NKTR?
Track your performance easily

Nektar Therapeutics (NKTR) Income Statement

1,232 Followers

Nektar Therapeutics Income Statement

Last quarter (Q3 2024), Nektar Therapeutics's total revenue was $24.12M, a decrease of -0.08% from the same quarter last year. In Q3, Nektar Therapeutics's net income was $-37.06M. See Nektar Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 93.14M$ 90.12M$ 92.06M$ 101.91M$ 152.91M$ 114.62M
Cost of Revenue
$ 29.99M$ 33.77M$ 21.64M$ 24.90M$ 19.48M$ 21.37M
Gross Profit
$ 63.15M$ 56.35M$ 70.42M$ 77.01M$ 133.44M$ 93.24M
Operating Expense
$ 199.04M$ 191.58M$ 310.66M$ 523.11M$ 513.36M$ 533.28M
Operating Income
$ -153.06M$ -263.68M$ -376.17M$ -446.10M$ -425.11M$ -440.04M
Net Non Operating Interest Income Expense
$ 17.88M$ 6.33M$ 22.13M-$ -6.85M$ -21.31M
Other Income Expense
$ -125.87M$ -134.71M$ -102.62M$ 69.15M$ 11.98M$ -21.29M
Pretax Income
$ -168.31M$ -276.26M$ -364.98M$ -523.28M$ -443.95M$ -440.05M
Tax Provision
$ -9.00K$ -200.00K$ 3.21M$ 557.00K$ 493.00K$ 613.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -168.30M$ -276.06M$ -368.20M$ -523.84M$ -444.44M$ -440.67M
Basic EPS
$ -0.83$ -1.45$ -1.97$ -2.86$ -2.49$ -2.52
Diluted EPS
$ -0.83$ -1.45$ -1.97$ -2.86$ -2.49$ -2.52
Basic Average Shares
$ 803.89M$ 190.00M$ 187.14M$ 183.30M$ 178.58M$ 174.99M
Diluted Average Shares
$ 803.89M$ 190.00M$ 187.14M$ 183.30M$ 178.58M$ 174.99M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 229.03M$ 225.35M$ 332.29M$ 548.01M$ 532.84M$ 554.65M
Net Income From Continuing And Discontinued Operation
$ -168.30M$ -276.06M$ -368.20M$ -523.84M$ -444.44M$ -440.67M
Normalized Income
$ -83.37M$ -109.73M----
Interest Expense
------
EBIT
$ -155.91M$ -250.92M$ -336.07M$ -475.97M$ -406.83M$ -418.74M
EBITDA
$ -150.20M$ -243.11M$ -323.04M$ -461.82M$ -392.65M$ -405.59M
Currency in USD

Nektar Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis